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Epidermal Stem Cells Have the Potential to Assist
in Healing Damaged Tissues
Jackie R. Bickenbach1,2, Matthew M. Stern1,2, Katie L. Grinnell1,2, Antonio Manuel1,2
and Sathivel Chinnathambi1,2
Homeostasis of continuously renewing tissues, such as the epidermis, is maintained by somatic undiffer-
entiated, self-renewing stem cells, which are thought to persist throughout life. Through a series of labeling
experiments, we previously showed that stem cells from mouse skin did not divide often, but they did divide at
a steady rate in vivo. Using our recently redefined sorting method, we isolated epidermal stem and transit
amplifying (TA) cells from mouse skin. When injected into a developing blastocyst or into damaged tissues, the
stem cells, but not the TA cells, could participate in the formation of new tissues. We hypothesize that all tissues
contain reserved undifferentiated stem cells that are primed to react if needed. These reserve stem cells could
restore the tissue in which they reside or they could be called upon to help restore another tissue that was
severely damage.
Journal of Investigative Dermatology Symposium Proceedings (2006) 11, 118–123. doi:10.1038/sj.jidsymp.5650009
SOMATIC STEM CELLS OF THE EPIDERMIS
Overall, it is generally agreed that homeostasis of the
continuously renewing interfollicular epidermis is maintained
by a small population of stem cells. Basically, a stem cell is
considered to be an undifferentiated cell, which is both self-
renewing and the source of all cells in that tissue. This is
thought to be accomplished by a mechanism of differential
cell division, where the undifferentiated stem cells divide to
produce daughter cells that maintain the stem cell phenotype
and daughter cells that are somehow changed in that they
now can undergo only a finite number of cell divisions before
they differentiate and leave the proliferative basal compart-
ment. How this differential cell division is accomplished is
not entirely understood, but in the epithelia of the small
intestine, cells in the stem cell niche appear to segregate their
DNA during cell division such that the stem cells retain the
original DNA template while the transit amplifying (TA)
daughter cells obtain the newly replicated DNA (Potten et al.,
2002). Thus, any mutations that occurred during replication
would be passed on to the TA daughter cells, leaving the stem
cell DNA unperturbed. Whether this is also true for stem cells
in skin epidermis has yet to be proven (for a review, see
Sherley, 2002).
Until recently, it was thought that somatic stem cells
contributed cells only to their particular tissue. However, it is
clear from several reports that many somatic stem cells,
including epidermal stem cells, have the capacity to
transdifferentiate into other cell types (e.g., see Krause
et al., 2001; Janes et al., 2002; Liang and Bickenbach,
2002; Verfaillie, 2002; Rosenthal, 2003). This bodes well for
the use of epidermal stem cells to repair tissues. The skin is
the largest organ of the body and the most easily accessible,
making epidermal stem cell isolation less problematic for the
patient, provided we can identify and isolate the appropriate
cells. This latter has been under investigation for several
decades.
Before the early 1980s, information available from
radiation and structural studies of the skin (Withers, 1967;
Mackenzie, 1969) suggested that the continuously renewing
epidermis should have a self-renewing stem cell population.
However, no direct evidence existed. Heterogeneity of the
epidermal proliferative compartment was first identified through
a series of nuclear label-retention studies (Bickenbach, 1981;
Bickenbach et al., 1986). Young growing mice were given
several injections of tritiated thymidine over 2 days, then
chased for up to 240 days. Samples of various epithelia were
fixed, sectioned, and coated with liquid emulsion. The
number of silver grains over each labeled cell was counted
for each time point and for each tissue (for example of
epidermis, see Figure 1). We showed that a few cells in the
interfollicular epidermis retained a nuclear label for up to 240
days. We called these label-retaining cells (LRCs). The
presence of LRCs with their slow loss of tritiated thymidine
over time (a reduction of the number of grains per cell)
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proved that the epidermal proliferative population contained
cells which cycled intermittently. Since that time LRCs have
been identified in several tissues, and to date, this is an
accepted method to identify epidermal stem cells (Tumbar
et al., 2004).
ISOLATION OF STEM CELLS FROM THE
INTERFOLLICULAR EPIDERMIS
To isolate LRCs, we used a modification and combination of
two previously published techniques (Barrandon and Green,
1985; Goodell et al., 1996, 1997). The first was a method for
isolating hematopoietic stem cells, which worked on the
principle that stem cells had more ABCG2 cell surface
pumps. This allowed them to easily exclude the vital Hoechst
33342 red/blue dye. Hematopoietic cells sorted by this
method proved to be highly enriched for the long-term in
vivo repopulative stem cells (Goodell et al., 1996, 1997). We
modified this method and combined it with a method for
isolating very small but highly proliferative keratinocytes
(Barrandon and Green, 1985). The combination of both
methods allowed us to use a flow cytometer to sort basal
keratinocytes into several populations with different recapi-
tulation and proliferative characteristics (Dunnwald et al.,
2001; Liang and Bickenbach, 2002; Liang et al., 2004;
Bickenbach and Stern, 2005). One population that we called
TA cells showed rapid in vitro proliferation, but inability to
maintain an epithelium, and no long-term expression of a
recombinant gene. Another population that we call stem cells
was B0.1% of the total basal cell population, expressed
keratin 14 (K14), formed large clones in culture, exhibited
much slower proliferation but much greater growth potential
in vitro than TA cells, reformed and maintained an epidermis
in organotypic culture, and expressed a recombinant gene for
a long period of time (Dunnwald et al., 2001; Liang and
Bickenbach, 2002; Liang et al., 2004; Bickenbach and Stern,
2005). Additionally, we showed that both neonatal and older
adult epidermal stem cells, but not the TA cells, could
produce cell lineages from all three germ layers in the
developing mouse (Liang and Bickenbach, 2002; Liang et al.,
2004). These cells could also assist in tissue recovery after
injury (Bickenbach and Stern, 2005), suggesting that the stem
cells retain a high level of tissue plasticity, whereas the TA
cells do not.
PLASTICITY OF INTERFOLLICULAR EPIDERMAL STEM
CELLS
The first evidence that somatic adult stem cells might be
pluripotent was reported in 1961 for the hematopoietic
system (Till and McCulloch, 1961). Hematopoietic progenitor
cells are identified by expression of the cell surface antigen
CD34 for human or Sca-1 and c-kit for mouse (Orlic et al.,
1994; Veer Reddy et al., 1997). Hematopoietic early
progenitor cells have also been identified as side population
cells by their ability to exclude Hoechst 33342 dye, and thus
located on the low side of the fluorescence in the scatter plots
from the flow cytometer (Goodell et al., 1996, 1997; Jackson
et al., 1999). These hematopoietic cells express the three
basic stem cell characteristics of self-renewal, unlimited
proliferative capacity, and the ability to differentiate into
various mature circulating blood cells (lymphocytes, macro-
phages, myelomonocytes, granulocytes, erythroid, etc)
(Lemischka et al., 1986; Keller and Snodgrass, 1990; Uchida
et al., 1993; Goodell et al., 1996; Iscove and Nawa, 1997). In
the past decade, it has been shown that pluripotentiality is not
limited to hematopoietic stem cells. For example, stem cells
located in intestinal crypts provide all four cell types of the
small intestine (paneth, enteroendocrine, goblet, and intes-
tinal epithelial cells) (Potten and Loeffler, 1990). In the eye,
both epithelial and goblet cells are derived from conjunctival
stem cells, and corneal cells are derived from limbal stem
cells (Wei et al., 1995, 1996; Miller et al., 1997; Pellegrini
et al., 1999). In addition, stem cells can transdifferentiate into
multiple tissues. For example, skeletal muscle cells have the
capacity to differentiate into hematopoietic cells (Jackson
et al., 1999), and adipose cells differentiated into chondro-
genic, myogenic, and osteogenic cells in the presence of
lineage-specific induction factors (Zuk et al., 2001). Multi-
potent mesenchymal cells were also reported (Pittenger et al.,
1999). Adult neural stem cells, injected into an irradiated
host, produced blood cells and early hematopoietic cells
(Bjornson et al., 1999), and hematopoietic stem cells injected
into the tail vein expressed neuronal phenotypes in the brain
(Brazelton et al., 2000; Mezey et al., 2000). A single bone
marrow stem cells produce cells that incorporate into all
three germ layers (Krause et al., 2001), and neonatal and old
adult epidermal stem cells can do the same (Liang and
Bickenbach, 2002; Liang et al., 2004; Bickenbach and Stern,
2005). There is some evidence from the Drosophila field that
transdifferentiation may be a general phenomenon that is
evolutionarily inherited (Wei et al., 2000). Thus, given the
appropriate environmental stimulus, somatic stem cells may
have the plasticity to form a variety of tissues.
The plasticity of epithelial cells isolated from whisker and
hair follicles have been extensively studied. It has been
suggested that cells from the bulge of the hair follicle produce
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Figure 1. Percentage of LRCs at 15, 30, 60, 90, and 240 days after labeling.
Cells were graphed and clustered according to the number of grains counted
per nucleus. Note, the gradual decrease in the number of grains per nuclei
with increasing time (purple to dark blue bar in each cluster). Also note that at
each time point after labeling, a few cells were heavily labeled (430 grains/
nucleus).
www.jidonline.org 119
JR Bickenbach et al.
Healing Damaged Tissues with Stem Cells
all the epithelial cells in the outer root sheath, inner root
sheath, and matrix, as well as cells in the interfollicular
epidermis, and cells in the sebaceous glands. Whether this is
a typical homeostatic mechanism is not clear. We do know
that when the skin is damaged, cells from the hair follicle
migrate into the interfollicular epidermis and into the
sebaceous gland (Taylor et al., 2000; Ghazizadeh and
Taichman, 2001). Recently, it was shown that a single-cell
cultured from either the bulge or the matrix of the rat whisker
follicle could contribute all the cell lineages of the hair
follicle and the sebaceous gland if grafted to the basement
membrane zone in neonatal mouse skin (Claudinot et al.,
2005). However, the grafting technique in itself creates a
wound, and thus may not truly represent homeostasis.
Furthermore, with an ever-increasing array of molecular
markers staining different epithelial cell population, it is
becoming apparent that follicular and interfollicular stem
cells may be distinct (Blanpain et al., 2004; Morris et al.,
2004; Tumbar et al., 2004; Levy et al., 2005)
Both embryonic and somatic stem cells have been
classified by their potential to contribute to other cell types
or tissues as totipotent (able to give rise to all embryonic and
extraembryonic cell types), pluripotent (able to give rise to all
cell types of the embryo proper), multipotent (able to give rise
to a subset cell lineages, usually in a tissue) (for a review, see
Wagers and Weissman, 2004). Somatic stem cells have also
been classified as plastic (able to change their phenotype or
to transdifferentiate into another cell type). However, the
mechanism of plasticity is poorly understood. It may be that
transdifferentiation is a phenomenon of one type of cell
fusing with another type of cell as suggested for the
hematopoietic and neural stem cells (Spees et al., 2002;
Terada et al., 2002; Ying et al., 2002; Vassilopoulos et al.,
2003; Wang et al., 2003). In our hands, neonatal epidermal
stem cells did not appear to fuse with embryonic stem cells
when grown together in culture. If fusion is not what is
causing plasticity of somatic stem cells, then three other
possibilities exist: (1) somatic stem cells might be disbursed
throughout other tissues; (2) genetic reprogramming might
take place when a somatic stem cell is placed in a new
environment; or (3) pluripotent cells left undifferentiated from
initial development might persist and be distributed through-
out all tissues. The latter possibility would require a shift in
the paradigm of stem cells. Furthermore, it appears clear that
an inductive influence may be required, such as that found in
a developmental environment or a damaged tissue (Levy
et al., 2005).
POTENTIAL OF EPIDERMAL STEM CELLS FOR TISSUE
REPLACEMENT
Follicular cells that were positive for CD34, but negative for
keratin 15 were shown to form several types of cells in vitro,
including neurons, glia, keratinocytes, smooth muscle cells,
and melanocytes (Toma et al., 2001). These data suggested
that such cells could be used to regenerate tissues after
wounding. When CD34-positive, keratin 15-negative, nestin-
positive cells were grafted into a gap in a severed sciatic
nerve, the cells transdifferentiated primarily into Schwann
cells. Importantly, they appeared to completely restore the
function of the severed nerve, for example, the rats could
walk again (Amoh et al., 2005). Thus, even though
transdifferentiation may not be a typical homeostatic function
of epithelial stem cells, these findings suggest that using them
for tissue regeneration is viable.
To examine the transdifferentiation potential of epidermal
stem cells under stress, we created full-thickness skin wounds
(6 mm punch biopsies) in the backs of young adult C57BL/6
mice. After 2 days, we injected green fluorescence protein
(GFP)þ epidermal stem cells just beneath the wound bed.
The GFPþ epidermal stem cells came from the back skin of
GFP transgenic neonatal mice. Controls received TA cells or
buffer only. The wounds that received the neonatal epidermal
stem cells appeared to heal faster in that by 4 days after
injection, the gross appearance of the wounds appeared
healed, whereas both sets of control wounds did not appear
healed until 7 days after injection. At 21 days, histological
analysis indicated that all the wounds were fully healed. In
wounds that received epidermal stem cells, we found GFPþ
cells in the underlying dermal tissues, including cells with an
adipocyte morphology within the fat layer (Figure 2). These
findings suggest that under the stress of wounding, mouse
epidermal stem cells have the ability to incorporate into the
healing dermal tissues.
Epidermal stem cells also show potential for non-skin
tissue replacement therapy. When GFPþ epidermal stem
cells were injected into the blood stream of lethally irradiated
mice, they helped the mice survive and appeared to help
repair their damaged bone marrow (Figures 3 and 4).
Recipient mice were irradiated with 1,100 cGy whole-body
g-radiation from a Cesium-137 source (broken into two doses
of 600 and 500 cGy, 3 h apart). After 24 h, 1105 GFPþ
Figure 2. Wounds receiving neonatal epidermal stem cells retain GFPþ
cells. Full-thickness skin wounds were created in the back skin of C57BL/6
non-transgenic mice. After 2 days, epidermal stem cells were isolated from
the back skin of neonatal GFP transgenic mice, and injected beneath the
wound beds. Shown here are adjacent sections through the middle of the
healed wound bed 21 days after GFPþ epidermal stem cells were injected.
(a) Hematoxylin- and eosin-stained section. (b) Unstained adjacent section
showing GFP fluorescence. Circle surrounds a cluster of GFPþ cells of
varying types. Arrows point to single GFPþ cell.
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epidermal stem cells were injected. For radioprotection, each
mouse received 1105 total bone marrow cells from non-
GFP-expressing mice. Control mice received TA epidermal
cells, bone marrow cells only, or buffer. We monitored the
mice for 8 months. All control mice receiving 2 105 bone
marrow cells lived for the entire 8 months; those who
received 1105 bone marrow cells died at 2 months. All
mice receiving epidermal stem cells lived the entire 8 months
(Figure 3). Mice receiving 1 105 TA cells did not fare as
well. By 4 months after irradiation, 60% (12 of 20 mice) were
dead, and by 8 months after injection, 80% were dead
(Figure 3). At 8 months, surviving mice that received TA cells
had no GFPþ cells in cell smears made from total bone
marrow isolates. In the bone marrow cell smears from mice
that received epidermal stem cells, only B1 in 1,000,000
were GFPþ . Although this is a very low percentage of
engraftment, some GFPþ cells in the circulating blood were
also positive for a cocktail of lineage markers (Figure 4),
indicating that at least a few epidermal stem cells contributed
to repopulating the hematopoietic tissue. These data suggest
that epidermal stem cells aid in the overall recovery of the
irradiated mice.
POTENTIAL TO IMPROVE TARGETING OF EPIDERMAL
STEM CELLS TO NON-SKIN TISSUES
To improve engraftment of epidermal stem cells to non-skin
tissue, it appears that we will have to alter the cells before
injection. One way to approach this is to change the cell’s
surface receptors. This could be carried out by transfecting or
transducing the cells with the appropriate gene. However, the
efficiency of most transfection methods is only 10–20% in
epidermal keratinocytes, thus requiring either injection of
many more cells or selection of only the cells that have been
transfected. Furthermore, if a viral vector is used to transduce
the gene, then the added risk of transferring viral proteins
might preclude these cells for future use in humans. We have
taken a different approach, and allowed the epidermal stem
cells to alter their own cell surface receptors in response to a
change in their environment. We isolated and cultured
mouse epidermal stem cells and epidermal TA cells. Both cell
types were grown in low calcium medium with 10%
chelexed serum, or in keratinocyte serum-free medium with
bovine pituitary extract in place of the serum, or in defined
keratinocyte serum-free medium, which is a defined medium.
To each cell type grown in each medium, we added 100 ng/
ml of IL-3, IL-6, stem cell factor, or stromal-derived factor-1a,
or a combination of 100 ng/ml IL-6 plus 100 ng/ml stromal-
derived factor-1a. These factors have been shown to
influence hematopoietic progenitor cells to enter specific
lineage pathways. After 3 days in culture, cells were double-
stained with antibodies to Sca-1 and K14. Sca-1 is found on
hematopoietic progenitors cells that have been in contact
with bone marrow stromal cells, and K14 is an intermediate
filament, which is expressed by basal keratinocytes. Cells
were scored as expressing Sca-1, K14, or both markers
(Figure 5). Five separate experiments were performed, and
200 cells counted in each experiment. TA cells did not
express Sca-1. Epidermal stem cells responded by expressed
Sca-1 in all treatment groups, with cells exposed to stromal-
derived factor-1a showing the most complete change.
Approximately, 97% of cells expressed Sca-1þ and no
longer expressing K14 (Figure 5). These data indicate that
under certain in vitro growth conditions, epidermal stem cells
can specifically respond to cytokines and alter their cell
surface expression to that of a hematopoietic cell surface
marker. It is interesting that the expression of Sca-1 on the
cell’s surface appears to be incompatible with the inter-
mediate filament K14, which was always seen in partial
collapse in co-expressing cells. Surprisingly, the type of
medium in which the cells were grown appeared to make
no difference in the overall results. We had expected
that the presence of serum in the medium might drastically
upregulate the Sca-1 expression. However, the control
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Figure 3. Survival graph of irradiated mice receiving epidermal stem
(EpiSC) or epidermal transit amplifying cells (EpiTA). Note that all the mice
receiving epidermal stem cells lived, whereas most of the mice receiving
epidermal TA cells died, suggesting that epidermal stem cells participated in
hematopoietic repopulation.
Figure 4. GFPþ Linþ cells present in peripheral blood of irradiated mice
8 months after receiving GFPþ epidermal stem cells. C57BL/6 mice were
lethally irradiated, then injected with GFP-expressing epidermal stem cells,
and the bone marrow examined. Panels show two pictures of the same area.
(a) Smear stained with an antibody cocktail of hematopoietic lineage markers
for macrophages/monocytes (CD11b, Mac-1), T-lymphocytes (CD5, CD3,
CD4, CD8), B-lymphocytes (CD45R,B220), granulocytes (Gr-1), and
erythrocytes (TER119), and then alkaline phosphatase-labeled secondary
antibody. (b) Smear stained with an antibody to GFP, and then horseradish
peroxidase-labeled secondary antibody. Arrows point to GFPþ cells that
are also hematopoietic lineage marker positive.
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cultures grown in serum, but without the addition of the
cytokines, showed continual expression of K14 and no
upregulation of Sca-1. Whether changing the epidermal
expression of Sca-1 in vitro before injecting the cells results in
an increased bone marrow engraftment of these cells remains
to be determined.
PARADIGM SHIFT
In conclusion, we have shown that stem cells can be highly
enriched from the epidermis of the skin, and that given the
appropriate stimulus, these cells appear to be induced to
transdifferentiate into cell types in tissues other than the
epidermis of the skin. How this takes place is not clear. It may
be that all tissues contain a small population of uncommitted
stem cells. Thus, we are not seeing true transdifferentiation.
Instead, we are inducing the uncommitted stem cells
population. We speculate that these cells remain sequestered
as reserved stem cells that sit in each tissue primed to react if
needed. These reserved stem cells could restore the tissue in
which they reside or they could be called upon to migrate
and help restore another tissue under severe damage. It has
been shown that in amphibians pluripotent epi-like stem cells
in the adult can form all types of cells and can express typical
embryonic markers (Young, 2004). Such cells were not
lineage committed in that 1% of these cells could form any
somatic tissue at any given time. They did not follow the
typical lineage pathway established in the embryo during
organogenesis. Tissue regeneration in the amphibian is owing
to the activation of the reserved population of quiescent
uncommitted stem cells to proliferate and commit to a
specific tissue lineage (Young, 2004). If this is true, then the
mechanism underlying the plasticity (fusion, or transdiffer-
entiation) of the stem cells is immaterial. For example,
somatic neural stem cells have a very broad developmental
capacity and the ability to contribute to the formation of a
variety of organs in both mouse and chick embryos (Clarke
et al., 2000). These mouse cells were cultured as neuro-
spheres, then injected as adherent neurospheres into chick
amniotic cavities or dissociated and injected directly into
mouse blastocysts. Both chick and mouse embryos showed a
mosaic pattern of cells derived from the neural stem cells,
indicating that the cells could commit to an altered lineage
pathway in development. More interestingly, these cells
appear to be able to form a committed lineage in a different
organism, suggesting that they may be more uncommitted
than previously thought. Our data suggest that epidermal
stem cells may also have this ability. We found that somatic
epidermal stem cells could contribute to a variety of tissues
during the development of a mouse and that they persisted
into adulthood (Liang and Bickenbach, 2002; Liang et al.,
2004). We have determined that they survive in zebrafish
embryos (Bickenbach and Stern, 2005), but we have not
tested whether they are interacting with the zebrafish cells.
Hematopoietic stem cells have been shown to incorporate
and function in a variety of murine tissues (Krause et al.,
2001). Furthermore, these uncommitted cells appear to exist
in all tissues and persist into adult tissues. Long-term
persistence of grafted male cells in females have been
reported (Flowers et al., 1990), as well as 27-year persistence
of male cells in the blood of females who had given birth to
male offspring (Bianchi et al., 1996). Although lifelong
persistence of single uncommitted stem cell has not been
proved, it is an attractive hypothesis and leads us to wonder
whether stem cells change with increasing age or whether
they remain as uncommitted, undifferentiated cells in all
tissues – just waiting to be called to act.
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